MAP4K3 and systemic lupus erythematosus: After verification of the induction of GLK–AhR–ROR-γt–IL-17A signaling in human SLE T cells, we next studied whether the GLK–AhR–ROR-γt signaling is a therapeutic target for autoimmune diseases.